CDC notes sharp declines in breast and cervical cancer screeningJuly 2, 2021OncologyHematologyBreast Cancer
Elevated factor VIII troughs can lead to a higher proportion of zero bleeds in hemophiliaJune 1, 2021HematologyOncology
Predicting outcomes in therapy-related AMLApril 22, 2021AMLLeukemia, Myelodysplasia, TransplantationHematologyOncology
GENUINE improvements: Ublituximab plus ibrutinib for CLLApril 21, 2021Leukemia, Myelodysplasia, TransplantationHematologyOncology
VEXAS: A novel rheumatologic, hematologic syndrome that’s making wavesApril 7, 2021Leukemia, Myelodysplasia, TransplantationHematology
FDA scrutinizes cancer therapies granted accelerated approvalMarch 18, 2021Breast CancerGenitourinary CancerLung CancerLymphoma & Plasma Cell DisordersMultiple MyelomaOncologyHematology
High-dose chemo no better than standard dose for B-cell lymphomaMarch 17, 2021Lymphoma & Plasma Cell DisordersHematologyOncology
‘Phenomenal’ results with CAR T cells in R/R multiple myelomaMarch 4, 2021Multiple MyelomaLymphoma & Plasma Cell DisordersHematologyOncology
CAR T-cell products shine in real-world setting, reveal new insightsFebruary 18, 2021Lymphoma & Plasma Cell DisordersOncologyHematology
FDA okays new CAR T-cell treatment for large B-cell lymphomasFebruary 8, 2021Lymphoma & Plasma Cell DisordersHematology
